Cargando…

Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment

Serine has been recently identified as an essential metabolite for oncogenesis, progression, and adaptive immunity. Influenced by many physiologic or tumor environmental factors, the metabolic pathways of serine synthesis, uptake, and usage are heterogeneously reprogrammed and frequently amplified i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shunxi, Wang, Xiaoxue, Yuan, Guanbin, Song, Li, Yang, Junyu, Jin, Wanqian, Liu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Nutrition 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509429/ https://www.ncbi.nlm.nih.gov/pubmed/37187454 http://dx.doi.org/10.1016/j.advnut.2023.05.007

Ejemplares similares

Matrix stiffness-dependent STEAP3 coordinated with PD-L2 identify tumor responding to sorafenib treatment in hepatocellular carcinoma
por: Wang, Shunxi, et al.
Publicado: (2022)

Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity
por: Njunge, Lucy Wanjiru, et al.
Publicado: (2020)

Metabolic reprogramming: a bridge between aging and tumorigenesis
por: Drapela, Stanislav, et al.
Publicado: (2022)

EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis
por: Yang, Tingting, et al.
Publicado: (2022)

Monocytes reprogrammed by tumor microparticle vaccine inhibit tumorigenesis and tumor development
por: Sun, Weiwei, et al.
Publicado: (2023)

PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism
por: Dai, Weixing, et al.
Publicado: (2022)

Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2022)

Tumor Cell‐Intrinsic SETD2 Deficiency Reprograms Neutrophils to Foster Immune Escape in Pancreatic Tumorigenesis
por: Niu, Ningning, et al.
Publicado: (2022)

Immune cell metabolism and metabolic reprogramming
por: Hu, Chenchen, et al.
Publicado: (2022)

TBC1D8 Amplification Drives Tumorigenesis through Metabolism Reprogramming in Ovarian Cancer
por: Chen, Min, et al.
Publicado: (2019)

Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
por: Xu, Yaolin, et al.
Publicado: (2021)

Reprogramming T-Cell Metabolism for Better Anti-Tumor Immunity
por: Ping, Yu, et al.
Publicado: (2022)

The role of lipid metabolic reprogramming in tumor microenvironment
por: Yang, Kai, et al.
Publicado: (2023)

Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma
por: Wu, Shaojie, et al.
Publicado: (2021)

Macrophages and Metabolic Reprograming in the Tumor Microenvironment
por: Liu, Jin, et al.
Publicado: (2022)

LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases
por: Zhang, Yanghe, et al.
Publicado: (2020)

Paracoccidioides brasiliensis presents metabolic reprogramming and secretes a serine proteinase during murine infection
por: Lacerda Pigosso, Laurine, et al.
Publicado: (2017)

Mitochondrial protein import determines lifespan through metabolic reprogramming and de novo serine biosynthesis
por: Lionaki, Eirini, et al.
Publicado: (2022)

Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy
por: Zhang, Jing, et al.
Publicado: (2023)

Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma
por: Clark, Rachael A., et al.
Publicado: (2022)

p53 connects tumorigenesis and reprogramming to pluripotency
por: Tapia, Natalia, et al.
Publicado: (2010)

Fusobacterium nucleatum-triggered purine metabolic reprogramming drives tumorigenesis in head and neck carcinoma
por: Li, Feiran, et al.
Publicado: (2023)

The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment
por: Zhou, Xijia, et al.
Publicado: (2023)

STAT3 serine phosphorylation is required for TLR4 metabolic reprogramming and IL-1β expression
por: Balic, Jesse J., et al.
Publicado: (2020)

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
por: Zhu, Yifei, et al.
Publicado: (2022)

The cancer metabolic reprogramming and immune response
por: Xia, Longzheng, et al.
Publicado: (2021)

Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma
por: Xia, Yujia, et al.
Publicado: (2021)

Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment
por: Ma, Guofeng, et al.
Publicado: (2022)

Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity
por: Zheng, Yue, et al.
Publicado: (2023)

Metabolism reprogramming signature associated with stromal cells abundance in tumor microenvironment improve prognostic risk classification for gastric cancer
por: Huo, Junyu, et al.
Publicado: (2022)

Caspase-10 inhibits ATP-citrate lyase-mediated metabolic and epigenetic reprogramming to suppress tumorigenesis
por: Kumari, Rajni, et al.
Publicado: (2019)

Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity
por: Flint, Thomas R., et al.
Publicado: (2016)

Metabolic reprogramming in tumors: Contributions of the tumor microenvironment
por: Lane, Andrew N., et al.
Publicado: (2019)

Recent Metabolomics Analysis in Tumor Metabolism Reprogramming
por: Han, Jingjing, et al.
Publicado: (2021)

Metabolic reprogramming in the immunosuppression of tumor-associated macrophages
por: Wang, Ying, et al.
Publicado: (2022)

Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
por: Jin, Hao-Ran, et al.
Publicado: (2023)

Oncogenic regulation of tumor metabolic reprogramming
por: Tarrado-Castellarnau, Míriam, et al.
Publicado: (2016)

Metabolic reprograming of tumor-associated macrophages
por: Puthenveetil, Abhishek, et al.
Publicado: (2020)

Metabolic Reprogramming in Tumor Endothelial Cells
por: García-Caballero, Melissa, et al.
Publicado: (2022)

Understanding metabolic reprogramming in tumor microenvironment
por: Shu, Shaokun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mmm13s0bdrva2gj2464hpo8nef